Annual Retained Earnings
-$305.63 M
-$96.66 M-46.25%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual retained earnings is -$305.63 million, with the most recent change of -$96.66 million (-46.25%) on December 31, 2023.
- During the last 3 years, OLMA annual retained earnings has fallen by -$272.54 million (-823.53%).
- OLMA annual retained earnings is now -4641.42% below its all-time high of -$6.45 million, reached on December 31, 2018.
Performance
OLMA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$401.54 M
-$34.55 M-9.42%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly retained earnings is -$401.54 million, with the most recent change of -$34.55 million (-9.42%) on September 30, 2024.
- Over the past year, OLMA quarterly retained earnings has dropped by -$122.68 million (-43.99%).
- OLMA quarterly retained earnings is now -3631.08% below its all-time high of -$10.76 million, reached on December 31, 2019.
Performance
OLMA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
OLMA Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.3% | -44.0% |
3 y3 years | -823.5% | -44.0% |
5 y5 years | -4641.4% | -44.0% |
OLMA Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -193.3% | at low | -285.4% | at low |
5 y | 5-year | -2739.9% | at low | -3631.1% | at low |
alltime | all time | -4641.4% | at low | -3631.1% | at low |
Olema Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$401.54 M(+9.4%) |
Jun 2024 | - | -$366.98 M(+9.0%) |
Mar 2024 | - | -$336.60 M(+10.1%) |
Dec 2023 | -$305.63 M(+46.3%) | -$305.63 M(+9.6%) |
Sep 2023 | - | -$278.86 M(+8.4%) |
Jun 2023 | - | -$257.36 M(+8.5%) |
Mar 2023 | - | -$237.26 M(+13.5%) |
Dec 2022 | -$208.98 M | -$208.98 M(+14.3%) |
Sep 2022 | - | -$182.80 M(+14.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | -$160.08 M(+25.8%) |
Mar 2022 | - | -$127.22 M(+22.1%) |
Dec 2021 | -$104.19 M(+214.8%) | -$104.19 M(+26.2%) |
Sep 2021 | - | -$82.55 M(+27.3%) |
Jun 2021 | - | -$64.84 M(+33.9%) |
Mar 2021 | - | -$48.43 M(+46.3%) |
Dec 2020 | -$33.09 M(+207.5%) | -$33.09 M(+44.1%) |
Sep 2020 | - | -$22.96 M(+113.4%) |
Dec 2019 | -$10.76 M(+67.0%) | -$10.76 M |
Dec 2018 | -$6.45 M | - |
FAQ
- What is Olema Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual retained earnings year-on-year change?
- What is Olema Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly retained earnings year-on-year change?
What is Olema Pharmaceuticals annual retained earnings?
The current annual retained earnings of OLMA is -$305.63 M
What is the all time high annual retained earnings for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual retained earnings is -$6.45 M
What is Olema Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, OLMA annual retained earnings has changed by -$96.66 M (-46.25%)
What is Olema Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of OLMA is -$401.54 M
What is the all time high quarterly retained earnings for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly retained earnings is -$10.76 M
What is Olema Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, OLMA quarterly retained earnings has changed by -$122.68 M (-43.99%)